Kidney Cancer Trial, Recruiting (NCT06153147)

Kidney Cancer Trial, Recruiting NCT06153147 Sponsor: The Hospital for Sick Children Condition: Kidney Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06153147 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Kidney Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are within 3 years (plus or minus 6 months) of finishing treatment for their first cancer
People whose first cancer treatment included at least one of the following high-risk therapies, as defined by the Canadian Oncology Group: alkylating agent chemotherapy drugs; platinum-based chemotherapy drugs; radiation to the abdomen or whole body; high-dose methotrexate; stem cell transplant; removal of a kidney (nephrectomy); or other treatments known to possibly cause long-term kidney or blood pressure problems

Who may not be able to join:

People who had severe chronic kidney disease before their cancer diagnosis, or who have previously had a kidney transplant
People who were older than 19 years of age at the point 3 years after completing their cancer treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 4168137605

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06153147

Sponsor: The Hospital for Sick Children

Phase: Not Applicable

Status: Recruiting

Condition: Kidney Cancer

Trial contact: 4168137605

More information: https://clinicaltrials.gov/study/NCT06153147

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are within 3 years (plus or minus 6 months) of finishing treatment for their first cancer
People whose first cancer treatment included at least one of the following high-risk therapies, as defined by the Canadian Oncology Group: alkylating agent chemotherapy drugs; platinum-based chemotherapy drugs; radiation to the abdomen or whole body; high-dose methotrexate; stem cell transplant; removal of a kidney (nephrectomy); or other treatments known to possibly cause long-term kidney or blood pressure problems

Who may not be able to join:

People who had severe chronic kidney disease before their cancer diagnosis, or who have previously had a kidney transplant
People who were older than 19 years of age at the point 3 years after completing their cancer treatment

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The Hospital for Sick Children

Registry

ClinicalTrials.gov

Start date

5 January 2024

Est. completion

25 October 2029

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Prevalence of Chronic Kidney Disease (CKD) based on eGFR (using an equation) at 3 years post cancer therapy; Prevalence of Chronic Kidney Disease (CKD) based on eGFR (using an equation) at 5 years post cancer therapy; Prevalence of Hypertension (HTN) from office blood pressure (vis blood pressure machine) at 3 years post cancer therapy; Prevalence of Hypertension (HTN) using Ambulatory Blood Pressure Measurement (ABPM) at 5 years post cancer therapy; Change in markers of kidney health (eGFR)(using an equation) between 3 and 5 years post cancer therapy; Change in markers of kidney health (Album...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov